PremiumCompany AnnouncementsUTime Limited Announces Strategic Shareholder Resolutions UTime Limited Announces $22.5 Million Private Placement and Upcoming Shareholder Meeting UTime Limited Completes $1.53 Million Private Placement PremiumCompany AnnouncementsUTime Limited Announces CFO Resignation and Interim Appointment UTime receives noncompliance notification from Nasdaq UTime Limited Registers New Shares with SEC PremiumThe FlyUTime initiates financial and legal due diligence on Bowen Therapeutics UTime signs NDA to acquire Bowen Therapeutics lab at UMASS UTime announces collaboration on Circul VS